Yazar "Yurdakul, Fatma Gül" için Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed listeleme
-
Clinical performance of ASAS health index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: Real-world evidence from Multicenter Nationwide Registry
Akgül, Özgür; Bodur, Hatice; Ataman, Şebnem; Yurdakul, Fatma Gül; Çapkın, Erhan; Gürer, Gülcan; Sezer, İlhan; Duruöz, Mehmet Tuncay; Alkan Melikoğlu, Meltem; Çay, Hasan Fatih; Rezvani, Aylin; Yağcı, İlker; Göğüs, Feride; Kamanlı, Ayhan; Çevik, Remzi (Springer Heidelberg, 2020)The Assessment of SpondyloArthritis international Society Health Index (ASAS HI) is used as a new instrument in measuring the function, disability and health of patients with spondyloarthritis (SpA). However, the real-world ... -
Clinical performance of rheumatoid arthritis impact of disease score: A real-life evidence from the multicenter nationwide registry BioStaR
Alkan Melikoğlu, Meltem; Ataman, Şebnem; Bodur, Hatice; Çay, Hasan Fatih; Çapkın, Erhan; Akgül, Özgür; Çevik, Remzi; Göğüş, Feride; Kamanlı, Ayhan; Yurdakul, Fatma Gül; Gürer, Gülcan; Yağcı, İlker; Rezvani, Aylin; Duruöz, Mehmet Tuncay; Sunar, İsmihan (Springer Heidelberg, 2021)The rheumatoid arthritis impact of disease (RAID) score was developed as a patient-derived composite response index for the evaluation of the disease impact on cases with rheumatoid arthritis (RA). The aim of this study ... -
Demographic and clinical characteristics of patients with sustained and switching treatments using biological and targeted synthetic disease-modifying antirheumatic drugs: A multicenter, observational cross-sectional study for rheumatoid arthritis
Ataman, Şebnem; Sunar, İsmihan; Bodur, Hatice; Alkan Melikoğlu, Meltem; Çay, Hasan Fatih; Çapkın, Erhan; Akgül, Özgür; Çevik, Remzi; Göğüş, Feride; Kamanlı, Ayhan; Yurdakul, Fatma Gül; Gürer, Gülcan; Yağcı, İlker; Rezvani, Aylin; Duruöz, Mehmet Tuncay (Springer, 2022)Introduction Rheumatoid arthritis is a chronic inflammatory disease with different disease activity grades. Several registries have been designed to determine the appropriate regimens of disease-modifying antirheumatic ... -
Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: A real-life evidence from biostar nationwide registry
Duruöz, Mehmet Tuncay; Ataman, Şebnem; Bodur, Hafize; Çay, H. F.; Alkan Melikoğlu, Meltem; Akgül, Özgür; Çapkın, Erol; Gürer, Gülcan; Çevik, Remzi; Göğüş, Feride Nur; Kamanlı, Ayhan; Yurdakul, Fatma Gül; Yağcı, İlker; Rezvani, Aylin; Altan İnceoğlu, Lale (BMJ Publishing Group, 2023)Background: Patients with rheumatoid arthritis (RA) have increased morbidity and mortality due to cardiovascular (CV) comorbidities. Objectives: The association of CV diseases (CVD) and traditional CV risk factors have ... -
Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: A real-life evidence from BioStaR nationwide registry
Bodur, Hatice; Yurdakul, Fatma Gül; Ataman, Şebnem; Çay, Hasan Fatih; Gürer, Gülcan; Çapkın, Erhan; Sezer, İlhan; Duruöz, Mehmet Tuncay; Alkan Melikoğlu, Meltem; Rezvani, Aylin; Yağcı, İlker; Göğüs, Feride; Kamanlı, Ayhan; Akgül, Özgür; Çevik, Remzi (Springer Science and Business Media Deutschland GmbH, 2022)Objectives Factors associated with disease activity of axial spondyloarthritis (axSpA) and switching of biologic disease-modifying anti-rheumatic drugs have not been clearly defined. We aimed to evaluate clinical characteristics ...